Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com



Growth: Bad revenue growth rate -4.9%, there is slowdown compared to average historical growth rates 12.1%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -4.1%

Profitability: LTM EBITDA margin is positive, +18.5%. On average the margin is improving unsteadily. Gross margin is high, +41.3%. In the last quarter the company beat the estimated EPS, 0.0%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.41 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.3%. Free cash flow yield -0.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 32.9% higher than minimum and 14.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.8x by EV / Sales multiple , the company can be 45.2% overvalued

Insiders: For the last 3 months insiders sold company shares on $78.8 mln (-0.035% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (+0.2%)573.55
year average price 529.88  


year start price 534.66 2023-05-09

min close price 431.41 2023-10-27

max close price 599.43 2024-03-11

current price 573.55 2024-05-07
Common stocks: 391 000 000

Dividend Yield:  0.3%
FCF Yield LTM: -0.2%
EV / LTM EBITDA: 27.2x
EV / EBITDA annualized: 25.3x
Last revenue growth (y/y):  -4.9%
Last growth of EBITDA (y/y):  0.6%
Historical revenue growth:  12.1%
Historical growth of EBITDA:  5.1%
EV / Sales: 5.0x
Margin (EBITDA LTM / Revenue): 18.5%
Fundamental value created in LTM:
Market Cap ($m): 223 801
Net Debt ($m): -7 967
EV (Enterprise Value): 215 834
Price to Book: 4.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-06Zacks Investment Research

Don't Overlook Thermo Fisher (TMO) International Revenue Trends While Assessing the Stock

2024-04-24Zacks Investment Research

Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up

2024-04-24Zacks Investment Research

Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics

2024-04-24Reuters

Thermo Fisher lifts profit forecast as medical equipment demand improves

2024-04-19Zacks Investment Research

Seeking Clues to Thermo Fisher (TMO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

2024-04-15Zacks Investment Research

What's in Store for Thermo Fisher (TMO) in Q1 Earnings?

2024-04-09InvestorPlace

Thermo Fisher Layoffs 2024: What to Know About the Latest TMO Job Cuts

2024-04-09Zacks Investment Research

Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers

2024-04-04Zacks Investment Research

Thermo Fisher Scientific Inc. (TMO) is Attracting Investor Attention: Here is What You Should Know

2024-04-02Zacks Investment Research

Thermo Fisher (TMO) Debuts a New In-Line Metrology Solution
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol TMO TMO TMO TMO TMO TMO TMO
reportedCurrency USD USD USD USD USD USD USD
cik 97 745 97 745 97 745 97 745 97 745 97 745 97 745
fillingDate 2024-05-03 2024-02-22 2023-11-03 2023-08-04 2023-05-05 2023-02-23 2022-11-04
acceptedDate 2024-05-03 11:04:00 2024-02-22 13:06:42 2023-11-03 13:04:16 2023-08-04 11:06:05 2023-05-05 11:41:34 2023-02-23 12:54:52 2022-11-04 14:12:20
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 10 345M 10 886M 10 574M 10 687M 10 710M 11 450M 10 677M
costOfRevenue 6 128M 6 390M 6 145M 6 323M 6 437M 6 715M 6 375M
grossProfit 4 217M 4 496M 4 429M 4 364M 4 273M 4 735M 4 302M
grossProfitRatio 0.408 0.413 0.419 0.408 0.399 0.414 0.403
researchAndDevelopmentExpenses 331M 327M 319M 345M 346M 391M 351M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 2 166M 1 672M 1 578M 1 673M 1 646M 1 836M 2 208M
otherExpenses 580M 643M 14M 768M 606M 592M 129M
operatingExpenses 2 497M 2 642M 2 481M 2 603M 2 598M 2 819M 2 688M
costAndExpenses 8 625M 9 032M 8 626M 8 926M 9 035M 9 534M 8 934M
interestIncome 279M 309M 246M 178M 146M 150M 68M
interestExpense -363M -390M 359M 326M 300M 269M 173M
depreciationAndAmortization 836M 839M 853M 855M 1 071M 1 088M 827M
ebitda 2 556M 1 854M 3 061M 2 794M 2 634M 2 949M 2 537M
ebitdaratio 0.247 0.170 0.289 0.261 0.246 0.258 0.238
operatingIncome 1 720M 1 854M 1 864M 1 578M 1 563M 1 861M 1 710M
operatingIncomeRatio 0.166 0.170 0.176 0.148 0.146 0.163 0.160
totalOtherIncomeExpensesNet -131M -114M -70M -183M -200M -84M -109M
incomeBeforeTax 1 589M 1 740M 1 765M 1 430M 1 363M 1 777M 1 601M
incomeBeforeTaxRatio 0.154 0.160 0.167 0.134 0.127 0.155 0.150
incomeTaxExpense 281M -133M 53M 52M 46M 173M 31M
netIncome 1 327M 1 630M 1 715M 1 361M 1 289M 1 576M 1 495M
netIncomeRatio 0.128 0.150 0.162 0.127 0.120 0.138 0.140
eps 3.470 4.210 4.440 3.530 3.340 4.030 3.820
epsdiluted 3.460 4.200 4.420 3.510 3.320 4.010 3.790
weightedAverageShsOut 382M 387M 386M 386M 386M 391M 392M
weightedAverageShsOutDil 384M 388M 388M 388M 388M 393M 395M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol TMO TMO TMO TMO TMO TMO TMO
reportedCurrency USD USD USD USD USD USD USD
cik 97 745 97 745 97 745 97 745 97 745 97 745 97 745
fillingDate 2024-05-03 2024-02-22 2023-11-03 2023-08-04 2023-05-05 2023-02-23 2022-11-04
acceptedDate 2024-05-03 11:04:00 2024-02-22 13:06:42 2023-11-03 13:04:16 2023-08-04 11:06:05 2023-05-05 11:41:34 2023-02-23 12:54:52 2022-11-04 14:12:20
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 5 506M 8 077M 6 151M 3 133M 3 482M 8 524M 2 919M
shortTermInvestments 1 751M 0 0 0 0 0 0
cashAndShortTermInvestments 7 257M 8 077M 6 151M 3 133M 3 482M 8 524M 2 919M
netReceivables 9 353M 8 221M 9 835M 9 486M 7 922M 8 274M 8 919M
inventory 5 133M 5 088M 5 404M 5 655M 5 664M 5 634M 5 722M
otherCurrentAssets 1 897M 3 203M 1 702M 1 721M 3 141M 2 933M 1 739M
totalCurrentAssets 23 640M 24 589M 23 092M 19 995M 20 209M 25 365M 19 299M
propertyPlantEquipmentNet 9 324M 9 448M 9 167M 9 292M 9 354M 9 280M 8 628M
goodwill 43 843M 44 020M 43 583M 43 273M 43 140M 41 196M 40 488M
intangibleAssets 16 048M 16 670M 17 091M 17 437M 17 972M 17 442M 17 813M
goodwillAndIntangibleAssets 59 891M 60 690M 60 674M 60 710M 61 112M 58 638M 58 301M
longTermInvestments 233M 59M 87M 6M 0 0 0
taxAssets 1 811M -59M 2 620M 2 842M 2 976M 0 0
otherNonCurrentAssets 2 196M 3 999M -2 620M -2 842M 1 007M 4 007M 4 308M
totalNonCurrentAssets 73 455M 74 137M 69 928M 70 008M 74 449M 71 925M 71 237M
otherAssets 0 0 4 037M 4 102M 0 0 0
totalAssets 97 095M 98 726M 97 057M 94 105M 94 658M 97 290M 90 536M
accountPayables 2 555M 2 872M 2 508M 2 423M 2 798M 3 381M 2 471M
shortTermDebt 4 451M 3 609M 4 795M 4 814M 6 122M 5 579M 1 010M
taxPayables 0 0 0 0 0 0 0
deferredRevenue 2 632M 2 689M 2 547M 2 590M 2 662M 2 601M 2 567M
otherCurrentLiabilities 4 299M 4 842M 4 308M 4 285M 4 302M 5 553M 5 070M
totalCurrentLiabilities 13 937M 14 012M 14 158M 14 112M 15 884M 17 114M 11 118M
longTermDebt 31 157M 31 308M 30 441M 29 007M 29 135M 28 909M 28 150M
deferredRevenueNonCurrent 1 427M -1 922M -9 566M -9 726M 0 0 0
deferredTaxLiabilitiesNonCurrent 1 811M 1 922M 2 620M 2 842M 2 976M 2 849M 3 140M
otherNonCurrentLiabilities 3 140M 6 564M 6 946M 6 884M 4 230M 4 270M 29 643M
totalNonCurrentLiabilities 37 535M 37 872M 30 441M 29 007M 36 341M 36 028M 35 691M
otherLiabilities 0 0 6 994M 7 071M 0 0 0
capitalLeaseObligations 31 157M 31 308M 30 489M 29 194M 29 135M 28 909M 28 150M
totalLiabilities 51 472M 51 884M 51 593M 50 190M 52 225M 53 142M 46 809M
preferredStock 0 0 3 027M 2 924M 0 0 0
commonStock 443M 442M 442M 441M 441M 441M 440M
retainedEarnings 48 542M 47 364M 45 869M 44 289M 43 064M 41 910M 40 452M
accumulatedOtherComprehensiveIncomeLoss -2 764M -3 224M -3 027M -2 924M -3 054M -3 099M -2 928M
othertotalStockholdersEquity -705M 2 142M -983M -978M 1 859M 4 780M 5 585M
totalStockholdersEquity 45 516M 46 724M 45 328M 43 752M 42 310M 44 032M 43 549M
totalEquity 45 623M 46 842M 45 464M 43 915M 42 310M 44 032M 43 549M
totalLiabilitiesAndStockholdersEquity 97 095M 98 726M 97 057M 94 105M 94 658M 97 290M 90 358M
minorityInterest 107M 118M 136M 163M 123M 116M 0
totalLiabilitiesAndTotalEquity 97 095M 98 726M 97 057M 94 105M 94 658M 97 290M 90 358M
totalInvestments 1 984M 59M 87M 6M 0 0 0
totalDebt 35 608M 34 917M 35 284M 34 008M 35 257M 34 488M 29 160M
netDebt 30 102M 26 840M 29 133M 30 875M 31 775M 25 964M 26 241M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol TMO TMO TMO TMO TMO TMO TMO
reportedCurrency USD USD USD USD USD USD USD
cik 97 745 97 745 97 745 97 745 97 745 97 745 97 745
fillingDate 2024-05-03 2024-02-22 2023-11-03 2023-08-04 2023-05-05 2023-02-23 2022-11-04
acceptedDate 2024-05-03 11:04:00 2024-02-22 13:06:42 2023-11-03 13:04:16 2023-08-04 11:06:05 2023-05-05 11:41:34 2023-02-23 12:54:52 2022-11-04 14:12:20
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 1 327M 1 630M 1 695M 1 362M 1 292M 1 574M 1 498M
depreciationAndAmortization 836M 839M 853M 855M 859M 848M 838M
deferredIncomeTax -253M -669M -303M -182M -146M -133M -261M
stockBasedCompensation 0 61M -150M -76M 76M 75M 77M
changeInWorkingCapital -787M 1 723M -9M -718M -1 533M 1 042M -367M
accountsReceivables 0 209M 0 0 0 -430M 0
inventory 0 598M 0 0 0 -825M 0
accountsPayables 0 -500M 0 0 0 648M 0
otherWorkingCapital -787M 1 416M -9M 0 0 1 649M 0
otherNonCashItems 1 800M 139M 328M 299M 181M 81M 152M
netCashProvidedByOperatingActivities 1 251M 3 723M 2 414M 1 540M 729M 3 487M 1 937M
investmentsInPropertyPlantAndEquipment -347M -405M -332M -284M -458M -550M -547M
acquisitionsNet 4M 11M -909M -47M -2 704M 0 1 000 000
purchasesOfInvestments -1 758M 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0
otherInvestingActivites 71M 18M 60M -112M 20M 25M 1 000 000
netCashUsedForInvestingActivites -2 030M -376M -1 181M -443M -3 142M -525M -545M
debtRepayment -1 205M -1 306M -1 494M -1 918M -523M -3 690M -200M
commonStockIssued 0 0 0 0 0 0 0
commonStockRepurchased -3 000M 0 0 0 -3 000M -1 000M 0
dividendsPaid -135M -136M -135M -135M -117M -117M -118M
otherFinancingActivites 110M 14M 3 484M 597M 1 047M 7 198M 167M
netCashUsedProvidedByFinancingActivities -1 821M -1 428M 1 855M -1 456M -2 593M 2 391M -151M
effectOfForexChangesOnCash 22M 10M -73M 12M -31M 250M -212M
netChangeInCash -2 577M 1 916M 3 015M -347M -5 037M 5 603M 1 029M
cashAtEndOfPeriod 5 506M 8 077M 6 168M 3 153M 3 500M 8 537M 2 934M
cashAtBeginningOfPeriod 8 083M 6 161M 3 153M 3 500M 8 537M 2 934M 1 905M
operatingCashFlow 1 251M 3 723M 2 414M 1 540M 729M 3 487M 1 937M
capitalExpenditure -347M -405M -332M -284M -458M -550M -547M
freeCashFlow 904M 3 318M 2 082M 1 256M 271M 2 937M 1 390M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Earning call transcript

2024 q1
2024-04-24 ET (fiscal 2024 q1)
2023 q4
2024-01-31 ET (fiscal 2023 q4)
2023 q3
2023-10-25 ET (fiscal 2023 q3)
2023 q2
2023-07-26 ET (fiscal 2023 q2)
2023 q1
2023-04-26 ET (fiscal 2023 q1)
2022 q4
2023-02-01 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-28 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-24 10:05 ET
Thermo Fisher Scientific to Host Investor Day
2024-04-24 10:00 ET
Thermo Fisher Scientific Reports First Quarter 2024 Results
2024-04-02 12:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024
2024-02-28 13:00 ET
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
2024-02-21 22:00 ET
Thermo Fisher Scientific Increases Quarterly Dividend
2024-01-31 11:00 ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
2024-01-04 13:00 ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
2024-01-03 13:00 ET
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
2024-01-02 13:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2024
2023-12-15 13:00 ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
2023-12-12 12:00 ET
Investing in the U.S. Health Care Sector with the Health Care Select Sector SPDR Fund (XLV)
2023-12-06 08:00 ET
Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt
2023-12-01 13:00 ET
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
2023-11-29 01:13 ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
2023-11-28 13:00 ET
Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
2023-11-14 13:00 ET
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
2023-11-09 22:00 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2023-10-25 10:00 ET
Thermo Fisher Scientific Reports Third Quarter 2023 Results
2023-10-17 12:19 ET
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
2023-10-04 06:00 ET
ViroCell Expands Business Development Team to Support Next Phase of Growth
2023-10-03 12:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2023
2023-09-07 12:00 ET
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
2023-09-06 12:00 ET
Thermo Fisher Scientific to Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 13, 2023
2023-08-25 12:00 ET
Thermo Fisher Scientific to Present at Handelsbanken 3rd Annual Life Science Innovation Day on August 30th, 2023
2023-08-14 20:30 ET
Audax Private Equity Completes Sale of CorEvitas
2023-08-14 20:10 ET
Thermo Fisher Scientific Completes Acquisition of CorEvitas
2023-08-08 00:15 ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
2023-07-26 10:00 ET
Thermo Fisher Scientific Reports Second Quarter 2023 Results
2023-07-13 21:00 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2023-07-13 20:30 ET
Thermo Fisher Scientific Elects New Director to Board
2023-07-06 12:15 ET
Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific
2023-07-06 12:00 ET
Thermo Fisher Scientific to Acquire CorEvitas
2023-07-05 12:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
2023-06-05 12:00 ET
Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery
2023-05-24 21:00 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2023-05-24 12:30 ET
Thermo Fisher Scientific Hosts 2023 Investor Day
2023-05-22 12:00 ET
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023
2023-05-19 12:00 ET
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia
2023-05-17 12:00 ET
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report
2023-05-09 12:15 ET
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets 
2023-05-02 12:00 ET
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023
2023-04-26 10:00 ET
Thermo Fisher Scientific Reports First Quarter 2023 Results
2023-04-10 12:00 ET
Thermo Fisher Scientific to Host Investor Day
2023-04-04 12:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023
2023-03-27 20:30 ET
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
2023-03-24 13:15 ET
Mark Stevenson Joins General Atlantic as Senior Advisor Focused on Life Sciences
2023-03-16 21:00 ET
GeminiBio Appoints Industry Veteran Cory Stevenson as Executive Chairman
2023-03-15 11:58 ET
Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer
2023-02-28 13:00 ET
Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023
2023-02-22 21:30 ET
Thermo Fisher Scientific Increases Quarterly Dividend
2023-02-02 13:00 ET
Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity
2023-02-01 11:00 ET
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results
2023-01-04 13:00 ET
Thermo Fisher Scientific to Present at 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
2023-01-03 13:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 1, 2023
2023-01-03 12:08 ET
Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
2023-01-03 12:00 ET
ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies
2022-12-06 13:00 ET
Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Net-zero Emissions
2022-11-21 13:00 ET
Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
2022-11-15 21:05 ET
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
2022-11-15 21:00 ET
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
2022-11-10 21:35 ET
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
2022-11-10 21:30 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2022-11-03 12:00 ET
Thermo Fisher Scientific and Society for Science Launch Junior Innovators Challenge to Inspire More Than 65,000 Future STEM Leaders Nationwide
2022-10-31 11:05 ET
Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy
2022-10-31 11:00 ET
Thermo Fisher Scientific to Acquire The Binding Site Group
2022-10-26 12:00 ET
MasterControl Honors Customers’ Achievements in Quality, Manufacturing, Analytics and Innovation at the Annual Masters of Excellence Gala.
2022-10-26 10:00 ET
Thermo Fisher Scientific Reports Third Quarter 2022 Results
2022-10-14 12:21 ET
Thermo Fisher Scientific Prices Offering of Yen-Denominated Senior Notes
2022-10-04 12:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
2022-09-29 12:00 ET
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
2022-09-14 16:17 ET
Gemini BioProducts Announces Addition to Board of Directors
2022-09-07 12:00 ET
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
2022-08-03 12:00 ET
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
2022-07-28 10:00 ET
Thermo Fisher Scientific Reports Second Quarter 2022 Results
2022-07-07 20:30 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2022-07-05 13:00 ET
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022
2022-06-06 12:00 ET
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
2022-06-02 12:00 ET
Thermo Fisher Scientific Releases Corporate Social Responsibility Report
2022-05-19 13:00 ET
Thermo Fisher Scientific Declares Quarterly Dividend
2022-05-06 12:00 ET
Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
2022-04-28 10:00 ET
Thermo Fisher Scientific Reports First Quarter 2022 Results
2022-04-21 15:00 ET
Portal Innovations Announces Partnership with Thermo Fisher Scientific

SEC forms

Show financial reports only

SEC form 10
2024-05-03 00:00 ET
Thermo Fisher Scientific reported for 2024 q1
SEC form 8
2024-04-24 06:03 ET
Thermo Fisher Scientific published news for 2024 q1
SEC form 8
2024-04-24 06:03 ET
Thermo Fisher Scientific reported for 2024 q1
SEC form 10
2024-02-22 00:00 ET
Thermo Fisher Scientific reported for 2023 q4
SEC form 8
2024-01-31 00:00 ET
Thermo Fisher Scientific published news for 2023 q4
SEC form 8
2024-01-31 00:00 ET
Thermo Fisher Scientific reported for 2023 q4
SEC form 10
2023-11-03 00:00 ET
Thermo Fisher Scientific reported for 2023 q3
SEC form 8
2023-10-25 06:03 ET
Thermo Fisher Scientific reported for 2023 q3
SEC form 10
2023-08-04 00:00 ET
Thermo Fisher Scientific reported for 2023 q2
SEC form 6
2023-07-26 06:02 ET
Thermo Fisher Scientific reported for 2023 q2
SEC form 8
2023-07-26 00:00 ET
Thermo Fisher Scientific reported for 2023 q2
SEC form 6
2023-07-13 16:31 ET
Thermo Fisher Scientific published news for 2023 q2
SEC form 6
2023-06-21 14:06 ET
Thermo Fisher Scientific published news for 2023 q1
SEC form 6
2023-05-26 16:16 ET
Thermo Fisher Scientific published news for 2023 q1
SEC form 10
2023-05-05 00:00 ET
Thermo Fisher Scientific reported for 2023 q1
SEC form 8
2023-04-26 00:00 ET
Thermo Fisher Scientific reported for 2023 q1
SEC form 10
2023-02-23 12:54 ET
Thermo Fisher Scientific reported for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Thermo Fisher Scientific published news for 2022 q4
SEC form 6
2023-02-01 06:05 ET
Thermo Fisher Scientific published news for 2022 q4
SEC form 8
2023-02-01 00:00 ET
Thermo Fisher Scientific reported for 2022 q4
SEC form 6
2022-11-21 16:59 ET
Thermo Fisher Scientific published news for 2022 q3
SEC form 6
2022-11-14 16:33 ET
Thermo Fisher Scientific published news for 2022 q3
SEC form 10
2022-11-04 14:12 ET
Thermo Fisher Scientific reported for 2022 q3
SEC form 10
2022-11-04 00:00 ET
Thermo Fisher Scientific reported for 2022 q3
SEC form 6
2022-10-26 06:07 ET
Thermo Fisher Scientific published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
Thermo Fisher Scientific reported for 2022 q3
SEC form 6
2022-10-20 16:02 ET
Thermo Fisher Scientific published news for 2022 q3
SEC form 10
2022-08-05 12:36 ET
Thermo Fisher Scientific reported for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Thermo Fisher Scientific reported for 2022 q2
SEC form 6
2022-07-28 06:08 ET
Thermo Fisher Scientific published news for 2022 q2
SEC form 8
2022-07-28 00:00 ET
Thermo Fisher Scientific reported for 2022 q2
SEC form 6
2022-06-16 13:27 ET
Thermo Fisher Scientific published news for 2022 q1
SEC form 6
2022-05-19 16:34 ET
Thermo Fisher Scientific published news for 2022 q1
SEC form 10
2022-05-06 14:53 ET
Thermo Fisher Scientific reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Thermo Fisher Scientific reported for 2022 q1
SEC form 6
2022-04-28 06:04 ET
Thermo Fisher Scientific published news for 2022 q1
SEC form 8
2022-04-28 00:00 ET
Thermo Fisher Scientific reported for 2022 q1
SEC form 6
2022-04-07 08:31 ET
Thermo Fisher Scientific published news for 2022 q1
SEC form 10
2022-02-24 12:58 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 10
2022-02-24 00:00 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 6
2022-02-23 18:01 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 6
2022-02-02 06:09 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 8
2022-02-02 00:00 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 6
2022-01-21 06:31 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 6
2022-01-07 16:10 ET
Thermo Fisher Scientific published news for 2021 q4
SEC form 6
2021-12-15 06:45 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-12-08 16:09 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-11-18 16:06 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 10
2021-11-04 15:55 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-10-27 06:06 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-10-22 16:03 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-10-18 16:18 ET
Thermo Fisher Scientific published news for 2021 q3
SEC form 6
2021-09-28 08:45 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 6
2021-09-17 08:45 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 6
2021-08-23 16:07 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 10
2021-08-06 11:12 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 10
2021-08-06 00:00 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 6
2021-07-28 06:21 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 8
2021-07-28 00:00 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 6
2021-07-09 09:01 ET
Thermo Fisher Scientific published news for 2021 q2
SEC form 6
2021-06-23 13:29 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-05-20 16:02 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 10
2021-05-07 15:12 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-04-29 06:14 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-04-16 17:26 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-04-15 07:10 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-04-08 08:26 ET
Thermo Fisher Scientific published news for 2021 q1
SEC form 6
2021-03-11 16:10 ET
Thermo Fisher Scientific published news for 2020 q4
SEC form 10
2021-02-24 17:36 ET
Thermo Fisher Scientific published news for 2020 q4
SEC form 6
2021-02-24 08:03 ET
Thermo Fisher Scientific published news for 2020 q4
SEC form 6
2021-02-01 06:34 ET
Thermo Fisher Scientific published news for 2020 q4
SEC form 6
2021-01-11 07:00 ET
Thermo Fisher Scientific published news for 2020 q4
SEC form 6
2020-12-04 16:10 ET
Thermo Fisher Scientific published news for 2020 q3
SEC form 6
2020-12-01 12:45 ET
Thermo Fisher Scientific published news for 2020 q3
SEC form 6
2020-11-20 16:15 ET
Thermo Fisher Scientific published news for 2020 q3
SEC form 10
2020-10-30 10:34 ET
Thermo Fisher Scientific published news for 2020 q3
SEC form 6
2020-10-21 06:18 ET
Thermo Fisher Scientific published news for 2020 q3